Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, UBIS (Asia) PCL's average Revenue per Share Growth Rate was 9.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -8.70% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -9.10% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -1.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of UBIS (Asia) PCL was 10.10% per year. The lowest was -13.40% per year. And the median was 4.00% per year.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
UBIS (Asia) PCL 3-Year Revenue Growth Rate Related Terms
BKK:UBIS-R vs LIN, SHW, ECL: 3-Year Revenue Growth Rate Comparison
For the Specialty Chemicals subindustry, UBIS (Asia) PCL's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
UBIS (Asia) PCL 3-Year Revenue Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, UBIS (Asia) PCL's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where UBIS (Asia) PCL's 3-Year Revenue Growth Rate falls into.
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
What does a 3-Year Revenue Growth Rate of -8.70% mean?
UBIS (Asia) PCL (BKK:UBIS-R) has a 3-Year Revenue Growth Rate of -8.70% as of Jun. 2026. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for UBIS (Asia) PCL and its competitors. According to the industry distribution chart, UBIS (Asia) PCL ranks #1184 out of 1532 companies in the Chemicals industry, placing it in the top 77.3%.
Is UBIS (Asia) PCL's 3-Year Revenue Growth Rate too high?
UBIS (Asia) PCL's current 3-Year Revenue Growth Rate is -8.70%. Based on the distribution chart, UBIS (Asia) PCL ranks #1184 out of 1532 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, UBIS (Asia) PCL has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does UBIS (Asia) PCL's 3-Year Revenue Growth Rate compare to LIN and SHW?
According to the Chemicals industry distribution chart, UBIS (Asia) PCL ranks #1184 out of 1532 companies for 3-Year Revenue Growth Rate. This places UBIS (Asia) PCL in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Revenue Growth Rate for a Chemicals company?
A good 3-Year Revenue Growth Rate depends on the Chemicals industry context. However, 3-Year Revenue Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Revenue Growth Rate mean?
A high 3-Year Revenue Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for UBIS (Asia) PCL and its competitors. UBIS (Asia) PCL's current 3-Year Revenue Growth Rate is -8.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UBIS (Asia) PCL stock overvalued right now?
Based on GuruFocus' analysis, UBIS (Asia) PCL (BKK:UBIS-R) is currently considered Fairly Valued. The stock's GF Value™ is ฿1.58, compared to a current price of ฿1.58 — trading 0.1% above its estimated fair value. The current 3-Year Revenue Growth Rate is -8.70%. UBIS (Asia) PCL's overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Revenue Growth Rate calculated?
3-Year Revenue Growth Rate is calculated from a company's financial statements. For UBIS (Asia) PCL (BKK:UBIS-R), the current 3-Year Revenue Growth Rate is -8.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is UBIS (Asia) PCL (BKK:UBIS-R) Overvalued in 2026?
Based on GuruFocus' analysis, UBIS (Asia) PCL stock appears to be overvalued.
The current stock price of ฿1.58 is trading 0.1% above its estimated GF Value™ of ฿1.58.
GuruFocus considers UBIS (Asia) PCL to be Fairly Valued.
Key valuation signals for BKK:UBIS-R:
3-Year Revenue Growth Rate: -8.70%
GF Value™: ฿1.58 vs. price of ฿1.58 (0.1% above fair value)
No single metric tells the full story. See the BKK:UBIS-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
UBIS (Asia) PCL is engaged in the business of manufacturing and distributing of sealing compounds, lacquers, and coatings used in can production and bottle closure for the food, beverage, and general industries. It operates in two business segments, each offering different products and services: Manufacturer and distributor of sealing compounds, lacquers and coatings and Other business The majority of the revenue is generated from the Manufacturer of sealing compounds, lacquers and coatings segment. Company operates in Thailand, China, and Others, with the majority of revenue from Other segment.
65GF Score
Get the complete analysis for BKK:UBIS-R
3-Year Revenue Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:UBIS-R has been successfully added to your 
